Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Medical Decision Making
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (21)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Stevenson, M. D.
Right arrow Articles by Chilcott, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stevenson, M. D.
Right arrow Articles by Chilcott, J. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Gaussian Process Modeling in Conjunction with Individual Patient Simulation Modeling: A Case Study Describing the Calculation of Cost-Effectiveness Ratios for the Treatment of Established Osteoporosis

M. D. Stevenson, PhD

Operational Research, School of Health and Related Research, University of Sheffield, 30 Regent Street, Sheffield, S1 4DA, England, UK.

J. Oakley, PhD

J. B. Chilcott, MSc

Individual patient-level models can simulate more complex disease processes than cohort-based approaches. However, large numbers of patients need to be simulated to reduce 1storder uncertainty, increasing the computational time required and often resulting in the inability to perform extensive sensitivity analyses. A solution, employing Gaussian process techniques, is presented using a case study, evaluating the cost-effectiveness of a sample of treatments for established osteoporosis. The Gaussian process model accurately formulated a statistical relationship between the inputs to the individual patient model and its outputs. This model reducedthe time required for future runs from 150 min to virtually-instantaneous, allowing probabilistic sensitivity analyses-to be undertaken. This reduction in computational time was achieved with minimal loss in accuracy. The authors believe that this case study demonstrates the value of this technique in handling 1st- and 2nd-order uncertainty in the context of health economic modeling, particularly when more widely used techniques are computationally expensive or are unable to accurately model patient histories.

Key Words: Gaussian process • individual patient simulation • osteoporosis

Medical Decision Making, Vol. 24, No. 1, 89-100 (2004)
DOI: 10.1177/0272989X03261561


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J Health Serv Res PolicyHome page
S. Griffin, K. Claxton, and M. Sculpher
Decision analysis for resource allocation in health care
J Health Serv Res Policy, October 1, 2008; 13(suppl_3): 23 - 30.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
H. Liu, K. Michaud, S. Nayak, D. B. Karpf, D. K. Owens, and A. M. Garber
The Cost-effectiveness of Therapy With Teriparatide and Alendronate in Women With Severe Osteoporosis.
Arch Intern Med, June 12, 2006; 166(11): 1209 - 1217.
[Abstract] [Full Text] [PDF]


Home page
Med Decis MakingHome page
N. Hawkins, M. Sculpher, and D. Epstein
Cost-Effectiveness Analysis of Treatments for Chronic Disease: Using R to Incorporate Time Dependency of Treatment Response
Med Decis Making, September 1, 2005; 25(5): 511 - 519.
[Abstract] [PDF]


Home page
Ann Rheum DisHome page
N J Bansback, A Brennan, and O Ghatnekar
Cost effectiveness of adalimumab in the treatment of patients with moderate to severe rheumatoid arthritis in Sweden
Ann Rheum Dis, July 1, 2005; 64(7): 995 - 1002.
[Abstract] [Full Text] [PDF]